Andy has worked in the pharmaceutical and information industries since 1999 in both large scale corporations and smaller PE-backed organizations. He has extensive global experience for business and offering strategy including product and service propositions, delivery mechanisms offered, prioritization, approval and governance of new and existing investments. He has been successful in developing and launching several scientific and commercial intelligence platforms helping to support critical BioPharma strategic investment decisions. Andy joined Hanson Wade in 2023 to lead the development of business intelligence and data product offerings.